Veritas In Silico Inc Sustainability Reports

The company operates a platform-based and pipeline-based biotechnology business focused on the discovery of mRNA-targeted small molecule drugs and antisense oligonucleotides using its proprietary drug discovery platform.

Sector: Professional & technical services

Country: Japan

Exchange: Tokyo Stock Exchange

FIGI: BBG00JM64274

No reports are currently available in our catalogue.